Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial

B Jia, X Zhang, N Ma, D Mo, F Gao, X Sun… - JAMA …, 2022 - jamanetwork.com
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …

European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease

M Psychogios, A Brehm… - European Stroke …, 2022 - journals.sagepub.com
The aim of the present European Stroke Organisation guideline is to provide clinically useful
evidence-based recommendations on the management of patients with intracranial …

Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review

G Li, H Qiao, H Lin, R Wang, F Chen, S Li… - Clinical Neurology and …, 2022 - Elsevier
Background Although percutaneous transluminal angioplasty and stenting (PTAS) was an
effective and safe alternative treatment for severe intracranial atherosclerosis disease …

Lipidomic Approaches in Common and Rare Cerebrovascular Diseases: The Discovery of Unconventional Lipids as Novel Biomarkers

A Potenza, G Gorla, T Carrozzini, A Bersano… - International Journal of …, 2023 - mdpi.com
Stroke remains a major cause of death and disability worldwide. Identifying new circulating
biomarkers able to distinguish and monitor common and rare cerebrovascular diseases that …

Baseline vessel wall magnetic resonance imaging characteristics associated with in-stent restenosis for intracranial atherosclerotic stenosis

B Tian, C Zhu, X Tian, Q Kang, C Shao… - Journal of …, 2023 - jnis.bmj.com
Background Imaging factors, specifically baseline plaque features on high-resolution
magnetic resonance vessel wall imaging (HR-VWI) that could be associated with in-stent …

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis

Y Yu, L Yan, Y Lou, R Cui, K Kang, L Jiang, D Mo… - Journal of …, 2021 - thejns.org
OBJECTIVE This study aimed to identify predictors of intracranial in-stent restenosis (ISR)
after stent placement in symptomatic intracranial atherosclerotic stenosis (ICAS). METHODS …

Effects of stent shape on focal hemodynamics in intracranial atherosclerotic stenosis: A simulation study with computational fluid dynamics modeling

H Liu, Y Liu, BYM Ip, SH Ma, J Abrigo, YOY Soo… - Frontiers in …, 2022 - frontiersin.org
Background and aims The shape of a stent could influence focal hemodynamics and
subsequently plaque growth or in-stent restenosis in intracranial atherosclerotic stenosis …

Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis

T Ueda, S Takaishi, T Yoshie, N Usuki, K Tatsuno… - BMC neurology, 2022 - Springer
Background The optimal treatment for intracranial artery stenosis (ICAS) has not been
established. We retrospectively examined the initial and long-term outcomes associated with …

A non-linear relationship between lesion length and risk of recurrent cerebral ischemia after stenting for symptomatic intracranial stenosis with hemodynamic …

X Zhang, W Gong, Z Meng, G Li, P Liu, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Stent placement can be an effective treatment for patients with symptomatic
intracranial stenosis (sICAS) and hemodynamic impairment (HI). However, the association …

[HTML][HTML] The use of pointwise encoding time reduction with radial acquisition MRA to assess middle cerebral artery stenosis pre-and post-stent angioplasty …

F Zhang, Y Ran, M Zhu, X Lei, J Niu, X Wang… - Frontiers in …, 2021 - frontiersin.org
Background and Purpose: 3D pointwise encoding time reduction magnetic resonance
angiography (PETRA-MRA) is a promising non-contrast magnetic resonance angiography …